CacheBy

Dimabio 제품 카탈로그

총 6,861개 제품 중 601–700번째 · 7 / 69 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.

  1. BME100221BBiotinylated Anti-IL5RA(benralizumab biosimilar) mAb
  2. BME100221PPE-conjugated Anti-IL5RA(benralizumab biosimilar) mAb
  3. BME100222Anti-TNFSF15(PF-06480605 biosimilar) mAb
  4. BME100222BBiotinylated Anti-TNFSF15(PF-06480605 biosimilar) mAb
  5. BME100222PPE-conjugated Anti-TNFSF15(PF-06480605 biosimilar) mAb
  6. BME100223Anti-IL12B(ebdarokimab biosimilar) mAb
  7. BME100223BBiotinylated Anti-IL12B(ebdarokimab biosimilar) mAb
  8. BME100224Anti-LY6E(RG7841 biosimilar) mAb
  9. BME100224BBiotinylated Anti-LY6E(RG7841 biosimilar) mAb
  10. BME100224PPE-conjugated Anti-LY6E(RG7841 biosimilar) mAb
  11. BME100225Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
  12. BME100225BBiotinylated Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
  13. BME100225PPE-conjugated Anti-CD79B (polatuzumab biosimilar) antibody, Rabbit IgG Chimeric mAb
  14. BME100226Anti-CRTAM(Oxford Biotherapeutics 5A11) mAb
  15. BME100226BBiotinylated Anti-CRTAM(Oxford Biotherapeutics 5A11) mAb
  16. BME100226PPE-conjugated Anti-CRTAM(Oxford Biotherapeutics 5A11) mAb
  17. BME100227Anti-CRTAM(HuC110‑34 biosimilar) mAb
  18. BME100227BBiotinylated Anti-CRTAM(HuC110‑34 biosimilar) mAb
  19. BME100227PPE-conjugated Anti-CRTAM(HuC110‑34 biosimilar) mAb
  20. BME100228Anti-ACVR2B(bimagrumab biosimilar) mAb
  21. BME100228BBiotinylated Anti-ACVR2B(bimagrumab biosimilar) mAb
  22. BME100228PPE-conjugated Anti-ACVR2B(bimagrumab biosimilar) mAb
  23. BME100229Anti-NKG2D(5C5 biosimilar, L234A/L235A) mAb
  24. BME100229BBiotinylated Anti-NKG2D(5C5 biosimilar, L234A/L235A) mAb
  25. BME100229PPE-conjugated Anti-NKG2D(5C5 biosimilar, L234A/L235A) mAb
  26. BME100230Anti-ADAM9(izeltabart biosimilar) mAb
  27. BME100230BBiotinylated Anti-ADAM9(izeltabart biosimilar) mAb
  28. BME100230PPE-conjugated Anti-ADAM9(izeltabart biosimilar) mAb
  29. BME100231Anti-IL31RA(nemolizumab biosimilar) mAb
  30. BME100231BBiotinylated Anti-IL31RA(nemolizumab biosimilar) mAb
  31. BME100231PPE-conjugated Anti-IL31RA(nemolizumab biosimilar) mAb
  32. BME100232Anti-CDH6(raludotatug biosimilar) mAb
  33. BME100232BBiotinylated Anti-CDH6(raludotatug biosimilar) mAb
  34. BME100232PPE-conjugated Anti-CDH6(raludotatug biosimilar) mAb
  35. BME100233Anti-CDH17(TORL-3-600 biosimilar) mAb
  36. BME100233PPE-conjugated Anti-CDH17(TORL-3-600 biosimilar) mAb
  37. BME100234Anti-CDH6(AMT-707 biosimilar) mAb
  38. BME100234PPE-conjugated Anti-CDH6(AMT-707 biosimilar) mAb
  39. BME100235Anti-IL1RL2(spesolimab biosimilar) mAb
  40. BME100235PPE-conjugated Anti-IL1RL2(spesolimab biosimilar) mAb
  41. BME100236Anti-PTK7(cofetuzumab biosimilar) mAb
  42. BME100236PPE-conjugated Anti-PTK7(cofetuzumab biosimilar) mAb
  43. BME100237Anti-LILRB4(MK-0482 biosimilar) mAb
  44. BME100237PPE-conjugated Anti-LILRB4(MK-0482 biosimilar) mAb
  45. BME100238Anti-CD98(HuM23 biosimilar) mAb
  46. BME100238PPE-conjugated Anti-CD98(HuM23 biosimilar) mAb
  47. BME100239Anti-IL18(camoteskimab biosimilar) mAb
  48. BME100240Anti-IL13RA1(eblasakimab biosimilar) mAb
  49. BME100240PPE-conjugated Anti-IL13RA1(eblasakimab biosimilar) mAb
  50. BME100241Anti-IL1RAP(nadunolimab biosimilar) mAb
  51. BME100241PPE-conjugated Anti-IL1RAP(nadunolimab biosimilar) mAb
  52. BME100242Anti-FGF23(burosumab biosimilar) mAb
  53. BME100243Anti-ILDR2(bapotulimab biosimilar) mAb
  54. BME100243PPE-conjugated Anti-ILDR2(bapotulimab biosimilar) mAb
  55. BME100244Anti-Her3(seribantumab biosimilar) mAb
  56. BME100244PPE-conjugated Anti-Her3(seribantumab biosimilar) mAb
  57. BME100245Anti-MET(emibetuzumab biosimilar) mAb
  58. BME100245PPE-conjugated Anti-MET(emibetuzumab biosimilar) mAb
  59. BME100246Anti-LEPR(mibavademab biosimilar) mAb
  60. BME100246PPE-conjugated Anti-LEPR(mibavademab biosimilar) mAb
  61. BME100247Anti-IGHE(omalizumab biosimilar) mAb
  62. BME100248Anti-ITGB6(sigvotatug biosimilar) mAb
  63. BME100249Anti-MUC1(PAb-001 biosimilar) mAb
  64. BME100249PPE-conjugated Anti-MUC1(PAb-001 biosimilar) mAb
  65. BME100250Anti-EGFR(QD6 biosimilar) mAb
  66. BME100250PPE-conjugated Anti-EGFR(QD6 biosimilar) mAb
  67. BME100251Anti-IL1RL2(imsidolimab biosimilar) mAb
  68. BME100251PPE-conjugated Anti-IL1RL2(imsidolimab biosimilar) mAb
  69. BME100252Anti-EGFR(depatuxizumab biosimilar) mAb
  70. BME100252PPE-conjugated Anti-EGFR(depatuxizumab biosimilar) mAb
  71. BME100253Anti-IL15(ordesekimab biosimilar) mAb
  72. BME100254Anti-IL10(BT 063 biosimilar) mAb
  73. BME100255Anti-F11(abelacimab biosimilar) mAb
  74. BME100256Anti-IL4(pascolizumab biosimilar) mAb
  75. BME100257Anti-DLL3(tarlatamab without CD3 biosimilar) mAb
  76. BME100258Anti-CD3E(tarlatamab without DLL3 biosimilar) mAb
  77. BME100259Anti-CX3CL1(quetmolimab biosimilar) mAb
  78. BME100260Anti-FGFR2(bemarituzumab biosimilar) mAb
  79. BME100261Anti-MET(telisotuzumab biosimilar) mAb
  80. BME100262Anti-CDH17(ADC-646-h7 biosimilar) mAb
  81. BME100263Anti-ST2(astegolimab biosimilar) mAb
  82. BME100264Anti-DLL3 and CD3(tarlatamab biosimilar) BsAb
  83. BME100265Anti-GPRC5D(MCARH109 biosimilar) mAb
  84. BME100266Anti-GREM1(ginisortamab biosimilar) mAb
  85. BME100267Anti-FCGR3A(AFM13 without CD30 biosimilar) mAb
  86. BME100268Anti-Canine IL31(lokivetmab biosimilar) mAb
  87. BME100269Anti-Feline IL31(dovanvetmab biosimilar) mAb
  88. BME100270Anti-FCGR3A(AFM13_VH_2 without CD30 biosimilar) mAb
  89. BME100271Anti-HEL Human IgG1(L234A/L235A)-Kappa Isotype control mAb
  90. BME100272Anti-HEL Mouse IgG1-Kappa Isotype control mAb
  91. BME100273Anti-HEL Mouse IgG2a-Kappa Isotype control mAb
  92. BME100274Anti-LIGHT(quisovalimab biosimilar) mAb
  93. BME100275Anti-SEZ6(ABBV-706 biosimilar) mAb
  94. BME100276Anti-TACI(G3D2 biosimilar) mAb
  95. BME100277Anti-Substance P(biosimilar) mAb
  96. BME100278Anti-Myc Tag(9E10) mAb
  97. BME100279Anti-BRIL(BAG2 biosimilar) mAb
  98. BME100280Anti-CD114(Anumigilimab biosimilar) mAb
  99. BME100283Anti-CXCR3 (53Hu37 biosimilar)mAb
  100. BME100284Anti-DNA(TMAB3,D31N biosimilar) mAb